Integrated Solid-Phase Extraction, Ultra-High-Performance Liquid Chromatography-Quadrupole-Orbitrap High-Resolution Mass Spectrometry, and Multidimensional Data-Mining Techniques to Unravel the Metabolic Network of Dehydrocostus Lactone in Rats

• Published in: Molecules (Basel, Switzerland) Switzerland), 2022-11, Vol.27 (22), p.7688
• Main Authors: Tian, Yingying, Ma, Beibei, Liu, Chuang, Zhao, Xinyue, Yu, Shangyue, Li, Yilin, Tian, Shiqiu, Pei, Hailuan, Wang, Zijian, Zuo, Zeping, Wang, Zhibin
• Format: Article
• Language: English
• Subjects: Acetylcysteine; Animals; Biological properties; Biological samples; Chromatography; Chromatography, High Pressure Liquid - methods; Conjugation; Data acquisition; Data collection; Data mining; Data Mining - methods; Data processing; data-mining techniques; Dehydration; dehydrocostus lactone (DL); Dehydrogenation; Drug metabolism; Extraction (Chemistry); Feces; Fluid filters; Glycine; Health aspects; Herbal medicine; High performance liquid chromatography; High resolution; Hydration; Hydroxylation; In vivo methods and tests; Inflammation; Ions; Lactones; Liquid chromatography; Mass spectrometry; Mass Spectrometry - methods; Mass spectroscopy; metabolic network; Metabolic networks; Metabolic Networks and Pathways; Metabolism; Metabolites; Methods; Methylation; Multidimensional data; Physiological aspects; Quadrupoles; Radiation; Rats; Scientific imaging; Solid Phase Extraction; Solid phases; solid-phase extraction (SPE); Spectroscopy; Sulfonation; Taurine; UHPLC–Q-Orbitrap HRMS; Urine
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules27227688

Dehydrocostus lactone (DL) is among the representative ingredients of traditional Chinese medicine (TCM), with excellent anticancer, antibacterial, and anti-inflammatory activities. In this study, an advanced strategy based on ultra-high-performance liquid chromatography-quadrupole-Orbitrap high-resolution mass spectrometry (UHPLC-Q-Orbitrap HRMS) was integrated to comprehensively explore the metabolic fate of DL in rats. First, prior to data collection, all biological samples (plasma, urine, and feces) were concentrated and purified using solid-phase extraction (SPE) pre-treatment technology. Then, during data collection, in the full-scan (FS) data-dependent acquisition mode, FS-ddMS was intelligently combined with FS-parent ion list (PIL)-dynamic exclusion (DE) means for targeted monitoring and deeper capture of more low-abundance ions of interest. After data acquisition, data-mining techniques such as high-resolution extracted ion chromatograms (HREICs), multiple mass defect filters (MMDFs), diagnostic product ions (DPIs), and neutral loss fragments (NLFs) were incorporated to extensively screen and profile all the metabolites in multiple dimensions. As a result, a total of 71 metabolites of DL (parent drug included) were positively or tentatively identified. The results suggested that DL in vivo mainly underwent hydration, hydroxylation, dihydrodiolation, sulfonation, methylation, dehydrogenation, dehydration, N-acetylcysteine conjugation, cysteine conjugation, glutathione conjugation, glycine conjugation, taurine conjugation, etc. With these inferences, we successfully mapped the "stepwise radiation" metabolic network of DL in rats, where several drug metabolism clusters (DMCs) were discovered. In conclusion, not only did we provide a refined strategy for inhibiting matrix effects and fully screening major-to-trace metabolites, but also give substantial data reference for mechanism investigation, in vivo distribution visualization, and safety evaluation of DL.